Does Helical Tomotherapy Improve Dose Conformity and Normal Tissue Sparing Compared to Conventional IMRT? A Dosimetric Comparison in High Risk Prostate Cancer
Abstract
The study was designed to compare Helical Tomotherapy (HT) based IMRT and conventional sliding window (SW IMRT) in patients with high risk prostate cancer. Complementary plans with HT and SWIMRT were compared using DVH parameters. The PTV Prostate was prescribed 74 Gy in 37 fractions and the nodal PTV received 55 Gy in 37 fractions by simultaneous integrated boost. Conformity Index, Homogeneity Index and dose-volume parameters were compared. The conformity index (CI) of HT (0.77, SD = 0.54) plans tended to be better (p = 0.069) compared to SWIMRT (0.70, SD = 0.01) for prostate PTV. CI for nodal PTV was similar. Helical tomotherapy plans were more homogeneous, with homogeneity index (HI) of 0.04 compared to 0.06 in SWIMRT (p = 0.018) for PTV prostate and HI of 0.06 and 0.15 (p = 0.025) for PTV nodes respectively. Median dose to bladder (p = 0.025) and rectum (p = 0.012) were less with HT. However, HT delivered a higher D10Gy and D1Gy to rectum and bladder overlap volumes as a consequence of achieving better homogeneity. Femoral heads were better spared with HT plans (p = 0.012). HT improves dose homogeneity, target coverage and conformity as compared to SWIMRT, with overall improvement in critical organ sparing.
References
1. Yeole B. B. Trends in the prostate cancer incidence in India. Asian Pac J Cancer Prev 9, 141–144 (2008).
2. Chung H. T., Xia P., Chan L. W., Park-Somers E., Roach M. III. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 73, 53–60 (2009).
3. Di Muzio N., Fiorino C., Cozzarini C., Alongi F., Broggi S., Mangili P., Guazzoni G., Valdagni R., Calandrino R., Fazio F. Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 74, 392–398 (2009).
4. Mackie T. R., Holmes T., Swerdloff S., Reckwerdt P., Deasy J. O., Yang J., Paliwal B., Kinsella T. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20, 1709–1719 (1993).
5. Shepard D. M., Olivera G. H., Reckwerdt P. J., Mackie T. R. Iterative approaches to dose optimization in tomotherapy. Phys Med Biol 45, 69–90 (2000).
6. Zelefsky M. J., Levin E. J., Hunt M., Yamada Y., Shippy A. M., Jackson A., Amols H. I. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70, 1124–1129 (2008).
7. Yuen J., Rodrigues G., Trenka K., Coad T., Yartsev S., D'Souza D., Lock M., Bauman G. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer. Radiat Oncol 3, 1 (2008).
8. Yang R., Xu S., Jiang W., Wang J., Xie C. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Acta Oncol 49, 230–236.
9. Lawton C. A., Michalski J., El-Naqa I., Buyyounouski M. K., Lee W. R., Menard C., O'Meara E., Rosenthal S. A., Ritter M., Seider M. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 74, 383–387 (2009).
10. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93 Suppl 3, 219–222 (2000).
11. Dearnaley D. P., Khoo V. S., Norman A. R., Meyer L., Nahum A., Tait D., Yarnold J., Horwich A. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 353, 267–272 (1999).
12. Shah A. P., Chen S. S., Strauss J. B., Kirk M. C., Coleman J. L., Coon A. B., Miller C., Dickler A. A Dosimetric Analysis Comparing Treatment of Low-Risk Prostate Cancer With TomoTherapy Versus Static Field Intensity Modulated Radiation Therapy. Am J Clin Oncol (2009).
13. Luo C., Yang C. C., Narayan S., Stern R. L., Perks J., Goldberg Z., Ryu J., Purdy J. A., Vijayakumar S. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer. Int J Radiat Oncol Biol Phys 66, 1253–1262 (2006).
14. Vaarkamp J., Adams E. J., Warrington A. P., Dearnaley D. P. A comparison of forward and inverse planned conformal, multi segment and intensity modulated radiotherapy for the treatment of prostate and pelvic nodes. Radiother Oncol 73, 65–72 (2004).
15. Cavey M. L., Bayouth J. E., Colman M., Endres E. J., Sanguineti G. IMRT to escalate the dose to the prostate while treating the pelvic nodes. Strahlenther Onkol 181, 431–441 (2005).
16. Sanguineti G., Cavey M. L., Endres E. J., Brandon G. G., Bayouth J. E. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? Int J Radiat Oncol Biol Phys 64, 151–160 (2006).
17. Tome W. A., Fowler J. F. On cold spots in tumor subvolumes. Med Phys 29, 1590–8 (2002).
18. Cao D., Holmes T. W., Afghan M. K., Shepard D. M. Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys 69, 240–250 (2007).
19. Ulrich S., Sterzing F., Nill S., Schubert K., Herfarth K. K., Debus J., Oelfke U. Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer. Med Phys 36, 4702–4710 (2009).
20. Sharma D. S., Gupta T., Jalali R., Master Z., Phurailatpam R. D., Sarin R. High-precision radiotherapy for craniospinal irradiation: Evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy. Br J Radiol 82, 1000–1009 (2009).
21. Gupta T., Basu A., Master Z., Jalali R., Munshi A., Sarin R. Planning and delivery of whole brain radiation therapy with simultaneous integrated boost to brain metastases and synchronous limited-field thoracic radiotherapy using helical tomotherapy: A preliminary experience. Technol Cancer Res Treat 8, 15–22 (2009).
22. Rodrigues G., Yartsev S., Chen J., Wong E., D'Souza D., Lock M., Bauman G., Grigorov G., Kron T. A comparison of prostate IMRT and helical tomotherapy class solutions. Radiother Oncol 80, 374–377 (2006).
23. Fokdal L., Honore H., Hoyer M., von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 74, 203–210 (2005).
24. Hysing L. B., Kvinnsland Y., Lord H., Muren L. P. Planning organ at risk volume margins for organ motion of the intestine. Radiother Oncol 80, 349–354 (2006).
25. Nutting C. M., Convery D. J., Cosgrove V. P., Rowbottom C., Padhani A. R., Webb S., Dearnaley D. P. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48, 649–656 (2000).
26. Nuyttens J. J., Robertson J. M., Yan D., Martinez A. The position and volume of the small bowel during adjuvant radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 51, 1271–1280 (2001).
27. Price R. A. Jr., Hannoun-Levi J. M., Horwitz E., Buyyounouski M., Ruth K. J., Ma C. M., Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys 66, 583–592 (2006).
28. Viani G. A., Stefano E. J., Afonso S. L. Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 74, 1405–1418 (2009).
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: April 1, 2011
Issue published: April 2011
Keywords
PubMed: 21381796
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in Technology in Cancer Research & Treatment.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 248
*Article usage tracking started in December 2016
Altmetric
See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 10 view articles Opens in new tab
Crossref: 8
- Effectiveness of robust optimization against geometric uncertainties i...
- Clinical Implementation and Initial Experience of Real-Time Motion Tra...
- Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone f...
- Impact of postoperative daily image-guided intensity-modulated radioth...
- Dose–volume histogram comparison between static 5-field IMRT with 18-M...
- Feasibility of prostate robotic radiation therapy on conventional C-ar...
- Management of High-Risk Localized Prostate Cancer
- The concept and challenges of TomoTherapy accelerators
Figures and tables
Figures & Media
Tables
View Options
View options
PDF/ePub
View PDF/ePubGet access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
